Variant · Snv
ATP5F1A NM_004046.6(ATP5F1A):c.94G>T (p.Ala32Ser)
CI-VAR-00058004Explore in graph →p.Ala32SerNM_004046.6:c.94G>TClinVar 381409 rs79011243
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 381409 | Benign | criteria provided, multiple submitters, no conflicts | 2 | ATP5F1A-related disorder; Melanoma; Acute myeloid leukemia; Malignant tumor of esophagus; Nonpapillary renal cell carcinoma; Uterine corpus endometrial carcinoma; Uterine carcinosarcoma; Thyroid cancer, nonmedullary, 1; Lung cancer; Malignant lymphoma, large B-cell, diffuse; Colon adenocarcinoma; Colorectal cancer; Sarcoma; Clear cell carcinoma of kidney; Gastric cancer; Thymoma; Cervical cancer | germline | 6 | Jan 25, 2026 | clinvar |